The patient was unknowingly infected with an abnormal protein that causes a rare, fatal neurological disease with no ...

Fujirebio recently announced that the US Food and Drug Administration (FDA) has granted clearance for the company’s Lumipulse in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...

Can a sports supplement help the brain battle Alzheimer’s? A new study finds creatine may boost a key energy pathway—and ...

The Alzheimer’s crisis hits close to home and work, but with new treatment advances that offer people facing the disease hope for more time with loved ones, there’s never been ...

New blood test approved for Alzheimer's diagnosis. The test measures two proteins in blood plasma, correlating with amyloid plaques in the brain.

Algernon Pharmaceuticals (CSE:AGN) has officially closed its acquisition of NoBrainer Imaging Centres, Inc., marking a ...

A new study links cold sores to Alzheimer's, highlighting HSV-1's role. Women in particular could have a higher risk. Anti-herpetic drugs may reduce dementia chances.

Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups ...

A new study published in Alzheimer’s & Dementia has identified 16 novel genetic regions associated with Alzheimer’s disease ...

Neurological symptoms such as dizziness, slurred speech, a splitting headache, numbness, and others may indicate a health ...